Search

everythinglearnresearchcommunity

for

Search:↓

Menopause and aging can affect women's quality of life and sexuality, but hormone therapies may help alleviate these issues.

There is no strong evidence that chemopreventive agents effectively prevent prostate cancer.

Finasteride and minoxidil are effective for hair loss, with potential side effects, and JAK inhibitors show promise for alopecia areata.

Hair loss might be due to nerve issues, treatable with electric stimulation or acupuncture.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might decrease the risk. AST also lessens the chance of cancer coming back but doesn't really affect survival rates. More research is needed to understand AST's benefits for different bladder cancers.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might reduce it. AST decreases recurrence-free survival but doesn't affect overall survival or progression-free survival. More research is needed to understand AST's benefits.

EX104 shows promise in treating hair loss by promoting hair growth and improving scalp health.

3α-androstanediol helps reduce age-related cognitive and mood declines in male rats, unlike testosterone.

Proxalutamide significantly lowered hospital admissions for male COVID-19 patients compared to a placebo.

Sex hormones may affect COVID-19 severity, with estrogen possibly reducing risk and testosterone potentially increasing it.

The new drug delivery system improves bicalutamide skin retention for better treatment of hair loss.

Oxytocin receptors are found in skin cells near touch and pain neurons.

New treatments for hair loss should target eight main causes and use specific plant compounds and peptides for better results.

New treatments for hair loss show promise with advanced therapies and better targeting.

More research is needed to understand how testosterone is maintained in adult males.

COVID-19 infection and vaccination may trigger hair loss and rapid hair whitening.

Men with androgenetic alopecia and hypertension may experience more severe COVID-19.

Vitamin D may help prevent or reduce hair loss after COVID-19.

New understanding and treatments for hair loss are improving, but more research is needed.

The document concludes that inflammation markers can be used in diabetes, vitamin D3 affects immune pathways, hyperthyroidism changes hormone levels, androgen levels help diagnose Adrenocortical Carcinoma, erectile dysfunction is linked to diabetes, hypogonadism is common in HIV-infected males, and hormones can be biomarkers for various conditions.

Stem cell treatments show promise for hair loss but need more research.

Plant-based compounds might be effective, low-side-effect treatments for prostate cancer by blocking a specific enzyme.

Treat significant hirsutism with medication and hair removal; use birth control pills first, adding antiandrogens if needed.

Nanotechnology could improve hair regrowth but faces challenges like complexity and safety concerns.

Proxalutamide improved recovery, lowered death rates, and reduced hospital stay for COVID-19 patients.

Adult female acne requires personalized treatment and maintenance to prevent relapse.

Menopause causes dry skin, wrinkles, and hair changes, with hormone therapy helping but not recommended just for these issues.

DN106212, an extract from a plant, is better at promoting hair growth than other tested substances by affecting hair growth factors and follicle development.

Dihydrotestosterone boosts inflammation in fat cells more than testosterone.

The conclusion is that understanding how hair follicle stem cells live or die is important for maintaining healthy tissue and repairing injuries, and could help treat hair loss, but there are still challenges to overcome.